While the chance of a blood clot from the J&J vaccine is astronomically low and vaccinating as many people as possible is a paramount goal, the government felt confident it could afford to stop its use.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.